We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-9.07%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$178M
AUM Growth
-$77.9M
Cap. Flow
-$57.1M
Cap. Flow %
-32.02%
Top 10 Hldgs %
66.72%
Holding
227
New
12
Increased
150
Reduced
51
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 38.44%
2 Technology 6.76%
3 Consumer Staples 6.63%
4 Consumer Discretionary 5.1%
5 Utilities 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
101
Goldman Sachs
GS
$300B
$263K 0.15%
885
+141
+19% +$43.9K
TMUS icon
102
T-Mobile US
TMUS
$185B
$263K 0.15%
1,954
-4
-0.2% -$522
BF.B icon
103
Brown-Forman Class B
BF.B
$13.2B
$262K 0.15%
3,729
-169
-4% -$11.3K
KO icon
104
Coca-Cola
KO
$377B
$261K 0.15%
4,155
-2,161
-34% -$137K
LLY icon
105
Eli Lilly
LLY
$1.02T
$261K 0.15%
806
-57
-7% -$17.1K
NEE icon
106
NextEra Energy
NEE
$181B
$261K 0.15%
3,367
+290
+9% +$22.1K
INCY icon
107
Incyte
INCY
$24.2B
$259K 0.15%
3,411
+305
+10% +$23.2K
SCHW
108
Charles Schwab
SCHW
$183B
$259K 0.15%
4,099
+1,062
+35% +$73.2K
T icon
109
AT&T
T
$159B
$259K 0.15%
12,345
-1,580
-11% -$31.5K
SLB icon
110
SLB Ltd
SLB
$73.6B
$258K 0.14%
7,206
-372
-5% -$15.5K
D icon
111
Dominion Energy
D
$60.8B
$257K 0.14%
3,224
+260
+9% +$21.5K
ABBV icon
112
AbbVie
ABBV
$443B
$256K 0.14%
1,674
+135
+9% +$20.6K
ZTS icon
113
Zoetis
ZTS
$32.4B
$256K 0.14%
1,491
+252
+20% +$43.6K
ED icon
114
Consolidated Edison
ED
$40.1B
$255K 0.14%
2,682
-50
-2% -$4.76K
KDP icon
115
Keurig Dr Pepper
KDP
$42.3B
$255K 0.14%
+7,196
New +$261K
RJF icon
116
Raymond James Financial
RJF
$33.8B
$255K 0.14%
2,856
+321
+13% +$31.5K
VZ icon
117
Verizon
VZ
$195B
$255K 0.14%
5,023
+425
+9% +$21.5K
ENPH icon
118
Enphase Energy
ENPH
$4.96B
$254K 0.14%
1,299
-129
-9% -$23.3K
DTE icon
119
DTE Energy
DTE
$29.5B
$253K 0.14%
2,000
+78
+4% +$10.2K
MRK icon
120
Merck
MRK
$322B
$252K 0.14%
2,763
-172
-6% -$15.2K
PFE icon
121
Pfizer
PFE
$143B
$252K 0.14%
4,813
+245
+5% +$12.5K
CNP icon
122
CenterPoint Energy
CNP
$27.7B
$251K 0.14%
8,474
-99
-1% -$3.05K
MS icon
123
Morgan Stanley
MS
$331B
$251K 0.14%
3,298
+436
+15% +$35.7K
REGN icon
124
Regeneron Pharmaceuticals
REGN
$78.5B
$251K 0.14%
425
+66
+18% +$42.9K
AEP icon
125
American Electric Power
AEP
$69.6B
$249K 0.14%
2,598
+47
+2% +$4.66K

Similar funds

Vantage Consulting Group's Q2 2022 Portfolio in Review

As of Q2 2022, Vantage Consulting Group held 227 positions worth $178M, down 30% from $256M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Vantage Consulting Group withdrew a net $57.1M in Q2 2022, closing 14 positions and reducing 51 holdings. Its most notable exit was NXP Semiconductors, an estimated $270K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 57% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Keurig Dr Pepper worth $255K.

  • Vantage Consulting Group's largest Q2 2022 buy was Keurig Dr Pepper: 7,196 shares worth $255K.
  • Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q2 2022, an estimated $10.4M increase.
  • Vantage Consulting Group's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $68.7M.
  • Vantage Consulting Group fully exited NXP Semiconductors in Q2 2022, selling an estimated $270K.
  • Vantage Consulting Group's ten largest holdings make up 67% of its $178M portfolio in Q2 2022.
  • Vantage Consulting Group opened 12 new positions and closed 14 in Q2 2022.
  • Vantage Consulting Group's portfolio value fell 30% quarter-over-quarter to $178M.

Based on Vantage Consulting Group's 13F filing for Q2 2022, filed 9 Aug 2022.